AU2002315848A1 - Remedies for eosinophilic diseases - Google Patents

Remedies for eosinophilic diseases

Info

Publication number: AU2002315848A1
Authority: AU; Australia
Prior art keywords: remedies; eosinophilic diseases; eosinophilic; diseases
Prior art date: 2001-06-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002315848A

Other versions

AU2002315848B2 (en

Inventor

Maki Matsubayashi

Kenji Matsumoto

Kenju Miura

Hirohisa Saito

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Asubio Pharma Co Ltd

Original Assignee

Asubio Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-22

Filing date

2002-06-21

Publication date

2003-06-19

2002-06-21 Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd

2002-06-21 Priority claimed from PCT/JP2002/006219 external-priority patent/WO2003000286A1/en

2003-06-19 Publication of AU2002315848A1 publication Critical patent/AU2002315848A1/en

2005-05-19 Assigned to SUNTORY LIMITED, DAIICHI SUNTORY PHARMA CO., LTD reassignment SUNTORY LIMITED Request for Assignment Assignors: DAIICHI SUNTORY BIOMEDICAL RESEARCH LTD., SUNTORY LIMITED

2006-01-19 Assigned to DAIICHI ASUBIO PHARMA CO., LTD. reassignment DAIICHI ASUBIO PHARMA CO., LTD. Request for Assignment Assignors: DAIICHI SUNTORY PHARMA CO., LTD.

2007-05-24 Assigned to ASUBIO PHARMA CO., LTD. reassignment ASUBIO PHARMA CO., LTD. Request for Assignment Assignors: DAIICHI ASUBIO PHARMA CO., LTD.

2008-05-15 Application granted granted Critical

2008-05-15 Publication of AU2002315848B2 publication Critical patent/AU2002315848B2/en

2022-06-21 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

206010052828 Eosinophilic disease Diseases 0.000 title 1

AU2002315848A 2001-06-22 2002-06-21 Remedies for eosinophilic diseases Ceased AU2002315848B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001-190083		2001-06-22
JP2001190083		2001-06-22
PCT/JP2002/006219 WO2003000286A1 (en)	2001-06-22	2002-06-21	Remedies for eosinophilic diseases

Publications (2)

Publication Number	Publication Date
AU2002315848A1 true AU2002315848A1 (en)	2003-06-19
AU2002315848B2 AU2002315848B2 (en)	2008-05-15

Family

ID=19028907

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002315848A Ceased AU2002315848B2 (en)	2001-06-22	2002-06-21	Remedies for eosinophilic diseases

Country Status (11)

Country	Link
US (1)	US20040156847A1 (en)
EP (1)	EP1405645A4 (en)
JP (1)	JPWO2003000286A1 (en)
CN (1)	CN1518459A (en)
AU (1)	AU2002315848B2 (en)
BR (1)	BR0210578A (en)
CA (1)	CA2451138A1 (en)
IL (1)	IL159478A0 (en)
NO (1)	NO20035352L (en)
NZ (1)	NZ530001A (en)
WO (1)	WO2003000286A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080233119A2 (en) *	2003-08-20	2008-09-25	University Of Miami	Compositions and methods for treating inflammatory lung disease
BRPI0607203A2 (en) *	2005-02-18	2009-08-25	Medarex Inc	isolated anti-cd30 antibody, host cell, methods for inhibiting cd30 + cell growth, and use of a defucosylated anti-cd30 antibody
CA2605508A1 (en) *	2005-05-12	2006-11-23	Wisconsin Alumni Research Foundation	Blockade of pin1 prevents cytokine production by activated immune cells
US20070128184A1 (en)	2005-08-30	2007-06-07	Eckhard Podack	Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
US9499627B2 (en)	2009-08-03	2016-11-22	University Of Miami	Method for in vivo expansion of T regulatory cells
ES2725569T3 (en) *	2012-02-10	2019-09-24	Seattle Genetics Inc	Diagnosis and treatment of cancers that express CD30
KR102565827B1 (en)	2013-01-09	2023-08-11	유니버시티 오브 마이애미	Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein
KR101611743B1 (en) *	2014-10-28	2016-04-11	인제대학교 산학협력단	Marker for diagnosing asthma Post-Bronchiolitis and Use thereof
CN110361546A (en) *	2019-08-28	2019-10-22	重庆三峡医药高等专科学校	A kind of colloidal gold strip detecting eosinophile cationic protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5165923A (en) *	1989-11-20	1992-11-24	Imperial Cancer Research Technology	Methods and compositions for the treatment of hodgkin's disease
ATE311895T1 (en) *	1992-05-26	2005-12-15	Immunex Corp	NEW CYTOKINE THAT BINDS CD30
AU777634B2 (en) *	1999-07-28	2004-10-28	Kazuhiro Aoki	Methods of inhibiting osteoclastogenesis

2002
- 2002-06-21 CA CA002451138A patent/CA2451138A1/en not_active Abandoned
- 2002-06-21 NZ NZ530001A patent/NZ530001A/en unknown
- 2002-06-21 WO PCT/JP2002/006219 patent/WO2003000286A1/en active Application Filing
- 2002-06-21 BR BR0210578-0A patent/BR0210578A/en not_active IP Right Cessation
- 2002-06-21 EP EP02741233A patent/EP1405645A4/en not_active Withdrawn
- 2002-06-21 CN CNA028125053A patent/CN1518459A/en active Pending
- 2002-06-21 IL IL15947802A patent/IL159478A0/en unknown
- 2002-06-21 JP JP2003506929A patent/JPWO2003000286A1/en active Pending
- 2002-06-21 AU AU2002315848A patent/AU2002315848B2/en not_active Ceased
2003
- 2003-12-01 NO NO20035352A patent/NO20035352L/en not_active Application Discontinuation
- 2003-12-19 US US10/739,300 patent/US20040156847A1/en not_active Abandoned

Similar Documents

Publication	Publication Date	Title
AU2001246876A1 (en)	2001-10-23	Remedies
AU2001246877A1 (en)	2001-10-23	Remedies
AU2002243032A1 (en)	2003-04-10	Remdies for infant chronic arthritis-relating diseases
AU2002343739A1 (en)	2003-05-26	Improved therapy for topical diseases
AU2001286221A1 (en)	2002-06-13	Remedies for ischemic diseases
AU2001252599A1 (en)	2001-11-12	Remedies for cancer
AU2000279614A1 (en)	2001-08-27	Remedies for endothelin-induced diseases
AU2001277711A1 (en)	2002-02-25	Remedies for cisplatin-tolerant cancer
AU2003272902A1 (en)	2004-04-23	Remedies
AU2002315848A1 (en)	2003-06-19	Remedies for eosinophilic diseases
IL159478A0 (en)	2004-06-01	Remedies for eosinophilic diseases
AU2001241162A1 (en)	2001-09-24	Remedies for allergic diseases
AU2001236006A1 (en)	2001-10-15	Preventives/remedies for kidney diseases
AU2003272962A1 (en)	2004-05-04	Remedies for allergic diseases
AU2001292301A1 (en)	2002-04-22	Novel drugs for liver diseases
AU2001228863A1 (en)	2001-08-14	Remedies for ophthalmic diseases
AU2001271026A1 (en)	2002-01-21	Remedies for bone diseases
AU2003227191A1 (en)	2003-10-08	Remedies for protozoan diseases
EP1426762A4 (en)	2007-05-09	Remedies for heart diseases
AU2003252479A1 (en)	2004-01-23	Remedies for respiratory diseases
AU2002232174A1 (en)	2002-09-24	Remedies for liver diseases
AU2002323902A1 (en)	2003-02-24	Remedies for prostatic diseases
AU2002362196A1 (en)	2003-09-02	Remedies for allergic diseases
AU2002335370A1 (en)	2003-03-24	Remedies for allergic diseases
AU2002327352A1 (en)	2003-02-24	Remedies for heart diseases